Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
2011

Extensively Drug-Resistant Tuberculosis in China

Sample size: 989 publication Evidence: moderate

Author Information

Author(s): Deng Yunfeng, Wang Yan, Wang Junling, Jing Hui, Yu Chunbao, Wang Haiying, Liu Zhimin, Graviss Edward A., Ma Xin

Primary Institution: Shandong Provincial Chest Hospital

Hypothesis

What is the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China?

Conclusion

The study found that 18.7% of multidrug-resistant tuberculosis strains in Shandong Province met the definition for XDR TB, which is higher than previous estimates in China.

Supporting Evidence

  • 32.3% of the analyzed isolates were resistant to at least one first-line drug.
  • 10.8% of the isolates were multidrug resistant.
  • 18.7% of the multidrug-resistant isolates were classified as extensively drug-resistant.

Takeaway

This study looked at a lot of tuberculosis samples in China and found that many of them were really hard to treat because they were resistant to many drugs.

Methodology

The study analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates collected from inpatients over a period from November 2004 to April 2007.

Potential Biases

The data collection was based in a TB hospital, which may not represent the general population's TB cases.

Limitations

The study may overestimate the prevalence of XDR and MDR TB due to a higher proportion of previously treated patients compared to other studies.

Participant Demographics

The mean age of participants was 40.1 years, with 65.5% being male.

Digital Object Identifier (DOI)

10.3201/eid1703.100812

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication